Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 20,650 shares at $0.25 ($5K) on 2008-01-16, disclosed to the SEC on 2008-01-17.
Open-market purchase of $5k ORMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 15,650 | $4K | 75.8% |
| 2 | $0.25 | 5,000 | $1K | 24.2% |
| Total | $0.25 avg | 20,650 | $5K | 100% |
| Filing → |
| ORMP | BUY | 2019-07-15 | $4K | — | Filing → |
| ORMP.OB | BUY | 2011-10-06 | $300K | — | Filing → |
| ORMP | BUY | 2008-01-09 | $7K | — | Filing → |